Originality
A vast and virgin structural space, protected with a double-layer IP.
Effective approach
Analogous and novel lipid tails of increased complexity are available within weeks from in-silico design.
Cost-effective
Fast and inexpensive access to predefined and/or proprietary lipids.
Proven scalability
No special reaction conditions are required, and SilBoRed™ has been proven to be an easy-to-handle reduction technology.
Simplicity
Standard lipids are available, cleaner and less expensive than via the currently available synthesis.
Lipid nanoparticle
A unique solution to one of the most pressing bottlenecks of the pharma industry – delivery of therapeutic oligonucleotides.
Accessibility
Using off-the-shelf and stable building blocks.
Modularity
Billions of novel lipids designed from building blocks accessible only using the SilBoRed™ reduction technology.
Originality
A vast and virgin structural space, protected with a double-layer IP.
Lipid nanoparticle
A unique solution for one of the most pressing bottlenecks of the pharma industry – delivery of RNA drugs and vaccines.
Cost-effective
Fast and inexpensive access to predefined and/or proprietary lipids.
Proven scalability
No special reaction condition are required and SilBoRed has been proven to be easy-to-handle reduction technology.
Effective approach
Analogous and novel lipid tails of increased complexity, within weeks from the in-silico design.
Effective approach
Analogous and novel lipid tails of increased complexity, within weeks from the in-silico design.
Accessibility
Using off-the-shelf stable building blocks.
Modularity
Billions of novel lipids to be designed from building blocks inaccessible to the standard chemical toolbox (Secondary IP).
Application
